Clinical Trials Directory

Trials / Unknown

UnknownNCT05915520

Baduanjin Program Effect on Geriatric Functional Dyspepsia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
65 Years – 75 Years
Healthy volunteers
Not accepted

Summary

functional dyspepsia is very common between geriatric population

Detailed description

Forty Egyptian geriatrics with functional dyspepsia, after randomization, will be divided to 2 groups; the first 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug. in the other 20-geriatric group, the daily dose of drug will be administered only for 8 weeks .

Conditions

Interventions

TypeNameDescription
BEHAVIORALbaduinjuin activitiesin this 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug)
OTHERpantoprazolein this 20-geriatric group will receive the daily dose of pantoprazole (40 mg orally administered tablet drug for 8 weeks .

Timeline

Start date
2023-07-20
Primary completion
2024-01-30
Completion
2024-01-30
First posted
2023-06-23
Last updated
2023-06-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05915520. Inclusion in this directory is not an endorsement.

Baduanjin Program Effect on Geriatric Functional Dyspepsia (NCT05915520) · Clinical Trials Directory